Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2383 | 2195 | 54.6 | 95% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
532 | 14062 | TOLL LIKE RECEPTOR//TOLL LIKE RECEPTORS//CD14 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RIG I | Author keyword | 88 | 58% | 5% | 103 |
2 | IRF3 | Author keyword | 38 | 53% | 2% | 50 |
3 | MDA5 | Author keyword | 37 | 61% | 2% | 40 |
4 | MAVS | Author keyword | 31 | 53% | 2% | 41 |
5 | RIG I LIKE RECEPTORS | Author keyword | 25 | 66% | 1% | 23 |
6 | TBK1 | Author keyword | 24 | 56% | 1% | 30 |
7 | LGP2 | Author keyword | 24 | 82% | 1% | 14 |
8 | IPS 1 | Author keyword | 23 | 72% | 1% | 18 |
9 | CARDIF | Author keyword | 21 | 90% | 0% | 9 |
10 | IRF 3 | Author keyword | 19 | 46% | 1% | 30 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RIG I | 88 | 58% | 5% | 103 | Search RIG+I | Search RIG+I |
2 | IRF3 | 38 | 53% | 2% | 50 | Search IRF3 | Search IRF3 |
3 | MDA5 | 37 | 61% | 2% | 40 | Search MDA5 | Search MDA5 |
4 | MAVS | 31 | 53% | 2% | 41 | Search MAVS | Search MAVS |
5 | RIG I LIKE RECEPTORS | 25 | 66% | 1% | 23 | Search RIG+I+LIKE+RECEPTORS | Search RIG+I+LIKE+RECEPTORS |
6 | TBK1 | 24 | 56% | 1% | 30 | Search TBK1 | Search TBK1 |
7 | LGP2 | 24 | 82% | 1% | 14 | Search LGP2 | Search LGP2 |
8 | IPS 1 | 23 | 72% | 1% | 18 | Search IPS+1 | Search IPS+1 |
9 | CARDIF | 21 | 90% | 0% | 9 | Search CARDIF | Search CARDIF |
10 | IRF 3 | 19 | 46% | 1% | 30 | Search IRF+3 | Search IRF+3 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RIG I | 294 | 36% | 30% | 661 |
2 | INDUCIBLE GENE I | 200 | 65% | 9% | 190 |
3 | INTRACELLULAR DNA | 163 | 72% | 6% | 128 |
4 | ANTIVIRAL RESPONSES | 154 | 33% | 18% | 385 |
5 | CYTOSOLIC DNA | 123 | 56% | 7% | 150 |
6 | LGP2 | 91 | 94% | 1% | 32 |
7 | IKK EPSILON | 87 | 56% | 5% | 105 |
8 | 5 TRIPHOSPHATE RNA | 79 | 72% | 3% | 62 |
9 | INTERFERON REGULATORY FACTOR 3 | 73 | 36% | 7% | 161 |
10 | CYCLIC GMP AMP | 72 | 59% | 4% | 82 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Viral RNA detection by RIG-I-like receptors | 2015 | 8 | 56 | 93% |
Pattern Recognition Receptors and Inflammation | 2010 | 1497 | 136 | 38% |
Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids | 2014 | 50 | 175 | 80% |
The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling | 2014 | 51 | 61 | 74% |
Cytosolic Sensing of Viruses | 2013 | 119 | 164 | 79% |
Immune Signaling by RIG-I-like Receptors | 2011 | 333 | 140 | 69% |
Pathogen recognition and innate immunity | 2006 | 4068 | 135 | 28% |
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | 2010 | 1992 | 132 | 17% |
STING-dependent cytosolic DNA sensing pathways | 2014 | 33 | 69 | 68% |
Immune Sensing of DNA | 2013 | 114 | 110 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AARHUS INNATE IMMUNOL | 18 | 83% | 0.5% | 10 |
2 | TERRY FOX MOL ONCOL GRP | 10 | 25% | 1.5% | 34 |
3 | MOL GENET NE20 | 4 | 75% | 0.1% | 3 |
4 | MOL ONCOL IMMUNOL PROGRAM | 4 | 75% | 0.1% | 3 |
5 | GRP INNATE IMMUN INFECT | 3 | 100% | 0.1% | 3 |
6 | GLOBAL HLTH EMERGING PATHOGENS | 3 | 11% | 1.1% | 24 |
7 | PROGRAM MOL VIROL | 3 | 38% | 0.3% | 6 |
8 | INNATE IMMUN IMMUNE DIS | 3 | 60% | 0.1% | 3 |
9 | ADJUVANT INNOVAT | 3 | 23% | 0.5% | 10 |
10 | DENVER MED JEWISH HLTH | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184188 | TIR DOMAIN//PELLINO//INNATE IMMUN INFLAMMAT |
2 | 0.0000171325 | UNC93B1//MARY KIRKLAND LUPUS//TLR7 |
3 | 0.0000155073 | IFN LAMBDA//IL 29//INTERLEUKIN 29 |
4 | 0.0000119031 | MX PROTEIN//MX GENE//MXA PROTEIN |
5 | 0.0000112274 | ISG15//ISGYLATION//HERC5 |
6 | 0.0000109103 | IRF 1//IRF 2//INTERFERON REGULATORY FACTOR 1 |
7 | 0.0000107802 | TOLL LIKE RECEPTOR 9//TOLL LIKE RECEPTOR 3//95D CELL |
8 | 0.0000095852 | IFI16//HIN 200//P202 |
9 | 0.0000086595 | IMMUNOPATHOL INFECT DIS GROUPING IRG GRI//TLR 3//BIOMETRY MED COMP |
10 | 0.0000086464 | IFITM3//IFITM1//IFITM |